Respiratory Devices Market to Grow from US$23.45 Billion in 2024 to US$49.90 Billion by 2033 at 8.8% CAGR as Therapeutic Devices Lead with 40% Share, Driven by Medtronic, Koninklijke Philips N.V., and ResMed Inc.

The Respiratory devices market size reached US$ 23.45 Billion in 2024 and is expected to reach US$ 49.90 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033 as healthcare systems worldwide increasingly prioritize advanced respiratory care solutions to manage rising incidences of chronic respiratory diseases, infectious conditions, and age-related pulmonary disorders.

Growth is driven by increasing demand across key product categories such as therapeutic respiratory devices, diagnostic and monitoring equipment, and consumables, supported by a growing patient pool suffering from conditions like COPD, asthma, sleep apnea, and respiratory failure. The expansion of home healthcare services, rising hospital admissions for respiratory illnesses, and increased awareness regarding early diagnosis and continuous monitoring are further accelerating market adoption. Additionally, technological advancements including portable oxygen concentrators, smart ventilators, AI-enabled diagnostic tools, and connected respiratory monitoring systems are enhancing patient outcomes and improving clinical efficiency. Rising healthcare expenditure, expanding healthcare infrastructure in emerging economies, and strong emphasis on critical care preparedness and infection control continue to drive sustained market expansion globally.

Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/respiratory-devices-market?sindhuri

Respiratory Devices Market: Competitive Intelligence
Medtronic, Koninklijke Philips N.V., ResMed Inc., GE HealthCare, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, Hamilton Medical, Nihon Kohden Corporation, Masimo, and Smiths Group plc are among the key global players shaping the competitive landscape of the Respiratory Devices Market. These companies offer a wide range of solutions including ventilators, oxygen therapy systems, CPAP and BiPAP devices, nebulizers, respiratory monitoring systems, and sleep apnea management solutions, designed to support critical care, home healthcare, emergency response, and long-term respiratory disease management.

The Respiratory Devices Market is primarily driven by the rising prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, along with increasing geriatric population globally and higher incidence of respiratory infections. Growing demand for home-based respiratory care, expansion of intensive care unit (ICU) infrastructure, and increased adoption of portable and wearable respiratory devices are further strengthening market growth. Additionally, regulatory emphasis on patient safety, improved clinical outcomes, and infection control standards continues to accelerate the adoption of advanced respiratory technologies across healthcare systems.

Competitive differentiation among these companies is shaped by strong innovation pipelines and technological integration. ResMed Inc. and Fisher & Paykel Healthcare lead in sleep apnea and non-invasive ventilation technologies, while Medtronic and GE HealthCare dominate critical care ventilator systems and hospital respiratory infrastructure. Drägerwerk AG & Co. KGaA and Hamilton Medical are strongly positioned in ICU ventilators and anesthesia-integrated respiratory solutions, whereas Masimo and Nihon Kohden Corporation focus on respiratory monitoring and patient connectivity. Strategic priorities include AI-enabled respiratory diagnostics, remote patient monitoring, tele-respiratory care platforms, portable oxygen solutions, and expansion into emerging healthcare markets with increasing respiratory care demand.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/respiratory-devices-market?sindhuri

Recent Key Developments - United States & North America
✅ June 2025: Philips Respironics expanded its next-generation sleep apnea and respiratory support portfolio in the U.S., focusing on advanced CPAP and ventilator safety enhancements for homecare and hospital use.
✅ May 2025: ResMed introduced AI-enabled cloud-connected respiratory care platforms to improve remote patient monitoring and therapy adherence across North American healthcare systems.
✅ 2025: Rising prevalence of COPD, asthma, and sleep apnea, along with growing home healthcare adoption, significantly increased demand for portable oxygen concentrators and non-invasive ventilation (NIV) systems.

Recent Key Developments - Japan & Asia-Pacific
✅ July 2025: Omron Healthcare expanded its respiratory therapy device portfolio in Japan and Southeast Asia, strengthening its position in portable nebulizers and oxygen therapy devices.
✅ Early 2026: Drägerwerk collaborated with Asian hospital networks to deploy advanced ICU ventilators and integrated respiratory monitoring systems in high-acuity care settings.
✅ 2025: Rapid aging population growth, rising air pollution levels, and increasing respiratory disease burden drove strong demand for oxygen therapy and critical care ventilation systems across APAC.

Recent Key Developments - Product & Technology Innovation
✅ 2025: Smart Ventilators: Growing adoption of AI-assisted ventilators enabled real-time patient parameter adjustments, improving critical care outcomes and reducing clinician workload.
✅ Remote Respiratory Monitoring: Expansion of IoT-enabled CPAP and BiPAP devices allowed continuous patient tracking, improving adherence in sleep apnea therapy.
✅ Portable Oxygen Solutions: Lightweight, battery-efficient portable oxygen concentrators saw increased adoption for homecare and ambulatory respiratory support, improving patient mobility and independence.

1.M&A / Strategic Activity
Recent strategic acquisitions, partnerships, and ecosystem developments shaping the respiratory devices market:
ResMed Inc. - Expansion in digital respiratory care ecosystem
In 2025, ResMed strengthened its respiratory care portfolio through strategic partnerships and acquisitions focused on sleep apnea therapy devices, cloud-connected ventilators, and AI-driven patient monitoring solutions.
Philips Respironics (Koninklijke Philips N.V.) - Recovery and portfolio restructuring
Philips continued strategic restructuring and partnerships in respiratory care, focusing on rebuilding its sleep and respiratory care business with enhanced safety standards and next-generation ventilator technologies.
Medtronic plc - Expansion in ventilator and respiratory monitoring ecosystem
Medtronic expanded collaborations with hospitals and homecare providers to strengthen its critical care ventilators, respiratory monitoring systems, and portable oxygen therapy solutions.
GE HealthCare Technologies Inc. - Strategic focus on critical care respiratory systems
GE HealthCare enhanced its ICU ventilator and respiratory support portfolio through partnerships with healthcare institutions to improve intensive care respiratory management.
Drägerwerk AG & Co. KGaA - Growth in hospital respiratory solutions
Dräger expanded its hospital respiratory care ecosystem through strategic alliances focused on anesthesia workstations, ventilators, and emergency respiratory support systems.

2.New Product/Service Launches & Deployments
Recent product innovations and deployments in the respiratory devices space:
ResMed Inc. - Next-generation CPAP and sleep apnea devices
ResMed launched advanced cloud-connected CPAP devices with AI-based sleep analytics and remote patient monitoring capabilities.
Philips Respironics - Advanced home ventilators and sleep therapy systems
Philips introduced improved sleep apnea therapy devices and portable ventilators with enhanced safety and connectivity features.
Medtronic plc - High-performance critical care ventilators
Medtronic deployed next-generation ICU ventilators with improved lung-protective ventilation modes and real-time respiratory analytics.
Fisher & Paykel Healthcare - Heated humidification and respiratory support systems
Fisher & Paykel launched upgraded humidification systems for non-invasive ventilation and high-flow nasal therapy.
Drägerwerk AG & Co. KGaA - Smart ICU ventilator platforms
Dräger introduced advanced ICU ventilators with integrated monitoring dashboards and adaptive ventilation modes for critical care patients.

3.R&D & Technological Advancements
AI-Driven Respiratory Monitoring & Diagnostics
AI and machine learning are increasingly integrated into respiratory devices to enable predictive analytics for sleep apnea, COPD, and critical care ventilation management.
Non-Invasive Ventilation (NIV) Innovations
Rapid advancements in NIV technologies are improving patient comfort and reducing the need for invasive mechanical ventilation in both hospital and homecare settings.
Portable and Home-Based Oxygen Therapy Systems
R&D is focused on compact, lightweight oxygen concentrators and home respiratory devices to support the growing demand for home healthcare.
Smart Connected Respiratory Devices (IoT Integration)
Connected respiratory devices enable remote monitoring, real-time data sharing, and telehealth integration for chronic respiratory disease management.
Energy-Efficient and Noise-Reduced Ventilation Systems
Continuous innovation is improving device efficiency, reducing noise levels, and enhancing usability in ICU and home environments.

Market Drivers & Emerging Trends
» Rising prevalence of chronic respiratory diseases (COPD, asthma, sleep apnea) driving demand for advanced respiratory devices.
» Increasing aging population globally boosting need for long-term oxygen therapy and ventilatory support.
» Expansion of home healthcare and remote patient monitoring accelerating adoption of portable respiratory devices.
» Growth in ICU admissions and critical care infrastructure strengthening demand for advanced ventilators.
» Rising adoption of AI, IoT, and connected healthcare devices improving respiratory disease management.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=respiratory-devices-market?sindhuri

Segments Covered in the Global Respiratory Devices Market:
By Product Type
The market is segmented into therapeutic devices (40%), monitoring devices (20%), diagnostic devices (15%), consumables & accessories (20%), and others (5%). Therapeutic devices dominate the market due to their extensive use in the treatment and management of chronic respiratory conditions such as COPD, asthma, and sleep apnea. Monitoring devices play a critical role in continuous patient assessment, while diagnostic devices support early detection and disease evaluation. Consumables & accessories maintain steady demand driven by recurring usage in hospitals and homecare settings.

By Application/Indication
Applications include Chronic Obstructive Pulmonary Disease (COPD) (30%), asthma (25%), sleep apnea (15%), pneumonia (10%), cystic fibrosis (5%), bronchitis (10%), and others (5%). COPD leads the segment due to its high global prevalence and long-term treatment requirements. Asthma follows closely, driven by rising pollution levels and increasing pediatric and adult cases. Sleep apnea is expanding rapidly due to growing awareness and diagnostic rates, while pneumonia and bronchitis remain significant contributors in both acute and chronic care settings.

By Portability
Portability includes stationary devices (55%) and portable devices (45%). Stationary devices dominate due to their widespread use in hospitals and clinical environments where advanced respiratory support systems are required. However, portable devices are witnessing strong growth, driven by increasing demand for homecare treatment, patient mobility, and remote monitoring solutions for chronic respiratory disease management.

By End-User
End-users include hospitals (45%), homecare settings (25%), ambulatory surgical centers (ASCs) (10%), clinics (10%), emergency medical services (EMS)/transport (5%), and others (5%). Hospitals dominate the segment due to high patient inflow, advanced infrastructure, and availability of critical care respiratory equipment. Homecare settings are growing rapidly with increasing preference for long-term, cost-effective, and patient-centric treatment solutions. ASCs, clinics, and EMS applications continue to support specialized and emergency respiratory care needs.

By Regions Covered
North America - 35% Share
North America leads the market due to advanced healthcare infrastructure, high prevalence of respiratory diseases, and strong adoption of technologically advanced respiratory care devices across the United States and Canada.

Europe - 25% Share
Europe is driven by increasing geriatric population, strong healthcare systems, and rising demand for home-based respiratory care solutions across countries such as Germany, the UK, France, and Italy.

Asia-Pacific - 25% Share
Asia-Pacific is expanding rapidly due to rising air pollution levels, increasing healthcare awareness, large patient population, and growing investments in healthcare infrastructure in countries such as China, India, and Japan.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.